Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018)

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018)

BackgroundRandomized controlled phase III trials have reported significant improvements in disease response and survival with the addition of chemotherapy to androgen deprivation therapy for men presenting with metastatic prostate cancer. We examined the implementation of such knowledge and its impa...

Full description

Bibliographic Details
Main Authors: Shihua Wang, Ming Yin, Peng Wang, Edmund Folefac, J. Paul Monk, Fred K. Tabung, Steven K. Clinton
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
chemotherapy
SEER
adenocarcinoma
neuroendocrine
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1165188/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1165188/full

Similar Items